These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 37166370)

  • 21. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
    Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
    Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.
    Spencer DA; Auffinger BM; Murphy JP; Muroski ME; Qiao J; Gorind Y; Lesniak MS
    Curr Cancer Drug Targets; 2017; 17(3):236-254. PubMed ID: 27993114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
    Papavassiliou KA; Papavassiliou AG
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Challenges and Opportunities in Treating Glioblastoma.
    Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N
    Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approaches to targeting gliomas at the leading/cutting edge.
    Schupper AJ; Hadjipanayis CG
    J Neurosurg; 2023 Sep; 139(3):760-768. PubMed ID: 36840741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.
    Alves ALV; Gomes INF; Carloni AC; Rosa MN; da Silva LS; Evangelista AF; Reis RM; Silva VAO
    Stem Cell Res Ther; 2021 Mar; 12(1):206. PubMed ID: 33762015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Directions in the Treatment of Glioblastoma.
    Reitman ZJ; Winkler F; Elia AEH
    Semin Neurol; 2018 Feb; 38(1):50-61. PubMed ID: 29548052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain tumor stem cells: Molecular characteristics and their impact on therapy.
    Schonberg DL; Lubelski D; Miller TE; Rich JN
    Mol Aspects Med; 2014 Oct; 39():82-101. PubMed ID: 23831316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspective of mesenchymal transformation in glioblastoma.
    Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
    Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
    Wu W; Klockow JL; Zhang M; Lafortune F; Chang E; Jin L; Wu Y; Daldrup-Link HE
    Pharmacol Res; 2021 Sep; 171():105780. PubMed ID: 34302977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.
    Hira VVV; Aderetti DA; van Noorden CJF
    J Histochem Cytochem; 2018 May; 66(5):349-358. PubMed ID: 29328867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioblastoma heterogeneity at single cell resolution.
    Eisenbarth D; Wang YA
    Oncogene; 2023 Jun; 42(27):2155-2165. PubMed ID: 37277603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial analysis of recurrent glioblastoma reveals perivascular niche organization.
    Onubogu U; Gatenbee CD; Prabhakaran S; Wolfe KL; Oakes B; Salatino R; Vaubel R; Szentirmai O; Anderson AR; Janiszewska M
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38805346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
    Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():882257. PubMed ID: 35651605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.
    Kardani K; Sanchez Gil J; Rabkin SD
    Front Cell Infect Microbiol; 2023; 13():1206111. PubMed ID: 37325516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of glioblastoma (GBM) molecular classification methods.
    Lee E; Yong RL; Paddison P; Zhu J
    Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal and tumourigenic boundaries of glioblastoma plasticity.
    De Silva MI; Stringer BW; Bardy C
    Trends Cancer; 2023 Mar; 9(3):223-236. PubMed ID: 36460606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.